Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids

Psychosomatics

Volumn 44, Issue 3, 2003, Pages 204-208

  Brown, E Sherwood ^a   Frol, Alan ^b   Bobadilla, Leonardo ^b   Nejtek, Vicki A ^b   Perantie, Dana C ^b   Dhillon, Harminder ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTEROID; LAMOTRIGINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; COGNITION; CORTICOSTEROID INDUCED PSYCHOSIS; DEPRESSION; DERMATOMYOSITIS; DRUG EFFECT; FEMALE; HAMILTON SCALE; HUMAN; MALE; MENTAL DISEASE; MOOD; PSYCHOSIS; RATING SCALE; RHEUMATOID ARTHRITIS;

EID: 0037408421     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.44.3.204     Document Type: Article

References (35)

1. Brown ES, Khan DA, Nejtek VA: The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol 1999; 83:495-504
2. Brown ES, Suppes T: Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 1998; 5:239-246
3. Brown ES, Suppes T, Khan DA, Carmody TJ: Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol 2002; 22:55-61
4. Naber D, Sand P, Heigl B: Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment: a prospective study. Psychoneuroendocrinology 1996; 21:25-31
5. Belanoff JK, Gross K, Yager A, Schatzberg AF: Corticosteroids and cognition. J Psychiatr Res 2001; 35:127-145
6. Brown ES, Rush AJ, McEwen BS: Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 1999; 21:474-484
7. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D: Cognitive effects of corticosteroids. Am J Psychiatry 1990; 147:1297-1303
8. Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL: Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999; 56:527-533
9. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME: Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 1994; 14:2047-2053
10. Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT: The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 1996; 47:1396-1402
11. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M: Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998: 19:269-301
12. McEwen BS, Weiss JM, Schwartz LS: Selective retention of corticosterone by limbic structures in rat brain. Nature 1968; 220:911-912
13. Zysset S, Muller K, Lohmann G, von Cramon DY: Color-word matching Stroop task: separating interference and response conflict. Neuroimaging 2001; 13:29-36
14. Vendrell P, Junque C, Pujol J, Jurado MA, Molet J, Grafman J: The role of prefrontal regions in the Stroop task. Neuropsychologia 1995; 33:341-352
15. Lupien SJ, Gillin CJ, Hauger RL: Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci 1999; 113:420-430
16. Lyons DM, Lopez JM, Yang C, Schatzberg AF: Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys. J Neurosci 2000; 20:7816-7821
17. Schatzberg AF, Posener JA, DeBattista C, Kalehzan BM, Rothschild AJ, Shear PK: Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry 2000; 157:1095-1100
18. Kim DK, Kim BL, Sohn SE, Lim SW, Na DG, Paik CH, Krishnan KR, Carroll BJ: Candidate neuroanatomic substrates of psychosis in old-aged depression. Prog Neuropsychopharmacol Biol Psychiatry 1999; 23:793-807
19. Preda A, Fazeli A, McKay BG, Bowers MB Jr, Mazure CM: Lamotrigine as prophylaxis against steroid-induced mania (letter). J Clin Psychiatry 1999; 60:708-709
20. Magariños A, Deslandes A, McEwen BS: Effects of antidepressants and benzodiazepam treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999; 371:113-122
21. Magariños AM, McEwen BS, Flugge G, Fuchs E: Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 1996; 16:3534-3540
22. Watanabe Y, Gould E, Cameron HA, Daniels DC, McEwen BS: Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 1992; 2:431-435
23. Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS: Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992; 222:157-162
24. Showalter PE, Kimmel DN: Stimulating consciousness and cognition following severe brain injury: a new potential clinical use for lamotrigine. Brain Inj 2000; 14:997-1001
25. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (Lamictal 602 Study Group): A double-blind placebocontrolled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999; 60:79-88
26. Brown ES, Bauer MS, Suppes T, Khan DA, Carmody T: Comparison of the internal state scale to clinician-administered scales in asthma patients receiving corticosteroid therapy. Gen Hosp Psychiatry 2000; 22:180-183
27. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
28. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
29. Bauer MS, Crits-Christoph P, Ball WA, Dewees E, McAllister T, Alahi P, Cacciola J, Whybrow PC: Independent assessment of manic and depressive symptoms by self-rating: scale characteristics and implications for the study of mania. Arch Gen Psychiatry 1991; 48:807-812
30. Rosenberg SJ, Ryan JJ, Prifitera A: Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. J Clin Psychol 1984; 40:785-787
31. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Washington, DC, American Psychiatric Press, 1995
32. Crawford JR, Stewart LF, Moore JW: Demonstration of savings on the AVLT and development of a parallel form. J Clin Exp Neuropsychol 1989; 11:975-981
33. Ryan JJ, Geisser ME, Randall DM, Georgemiller RJ: Alternate form reliability and equivalency of the Rey Auditory Verbal Learning Test. J Clin Exp Neuropsychol 1986; 8:611-616
34. Ramaratnam S, Marson AG, Baker GA: Lamotrigine add-on for drug-resistant partial epilepsy, in The Cochrane Database of Systematic Reviews. The Cochrane Library, The Cochrane Collaboration, 2002. http://www.cochrane.org
35. Margolin A, Avants SK, DePhilippis D, Kosten TR: A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am J Drug Alcohol Abuse 1998; 24:85-101